Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-20

Clinical Trial Update: Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

Phase 2 trial comparing FX006 to normal saline in knee osteoarthritis; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FX006

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED | Results posted: 2018-03-20